Cardiovascular and Noncardiovascular Mortality Among Patients Starting Dialysis

被引:646
作者
de Jager, Dinanda J. [1 ]
Grootendorst, Diana C. [1 ]
Jager, Kitty J. [2 ]
van Dijk, Paul C. [2 ]
Tomas, Lonneke M. J. [1 ]
Ansell, David [3 ]
Collart, Frederic [4 ]
Finne, Patrik [5 ]
Heaf, James G. [6 ]
De Meester, Johan [7 ]
Wetzels, Jack F. M. [8 ]
Rosendaal, Frits R. [1 ]
Dekker, Friedo W. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2300 RC Leiden, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, ERA EDTA Registry, Dept Med Informat, NL-1105 AZ Amsterdam, Netherlands
[3] United Kingdom Renal Registry, Bristol, Avon, England
[4] French Speaking Belgium ESRD Registry, Brussels, Belgium
[5] Finnish Registry Kidney Dis, Helsinki, Finland
[6] Copenhagen Univ Hosp, Dept Nephrol, Herlev, Denmark
[7] AZ Nikolaas, Dept Nephrol Dialysis & Hypertens, St Niklaas, Belgium
[8] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2009年 / 302卷 / 16期
关键词
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; RISK-FACTOR; HEMODIALYSIS; DEATH; DYSFUNCTION; PREVALENCE; REGISTRY; FRAILTY; GENDER;
D O I
10.1001/jama.2009.1488
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Context Cardiovascular mortality is considered the main cause of death in patients receiving dialysis and is 10 to 20 times higher in such patients than in the general population. Objective To evaluate if high overall mortality in patients starting dialysis is a consequence of increased cardiovascular mortality risk only or whether noncardiovascular mortality is equally increased. Design, Setting, and Patients Using data from between January 1, 1994, and January 1, 2007, age-stratified mortality in a European cohort of adults starting dialysis and receiving follow-up for a mean of 1.8 (SD, 1.1) years ( European Renal Association-European Dialysis and Transplant Association [ERA-EDTA] Registry [N=123 407]) was compared with the European general population (Eurostat). Main Outcome Measures Cause of death was recorded by ERA-EDTA codes in patients and matching International Statistical Classification of Diseases, 10th Revision codes in the general population. Standardized cardiovascular and noncardiovascular mortality rates, their ratio, difference, and relative excess of cardiovascular over noncardiovascular mortality were calculated. Results Overall all-cause mortality rates in patients and the general population were 192 per 1000 person-years (95% confidence interval [CI], 190-193) and 12.055 per 1000 person-years ( 95% CI, 12.05-12.06), respectively. Cause of death was known for 90% of the patients and 99% of the general population. In patients, 16 654 deaths (39%) were cardiovascular and 21 654 (51%) were noncardiovascular. In the general population, 7 041 747 deaths (40%) were cardiovascular and 10 183 322 (58%) were noncardiovascular. Cardiovascular and noncardiovascular mortality rates in patients were respectively 38.1 per 1000 person-years ( 95% CI, 37.2-39.0) and 50.1 per 1000 person-years ( 95% CI, 48.9-51.2) higher than in the general population. On a relative scale, standardized cardiovascular and noncardiovascular mortality were respectively 8.8 ( 95% CI, 8.6-9.0) and 8.1 ( 95% CI, 7.9-8.3) times higher than in the general population. The ratio of these rates, ie, relative excess of cardiovascular over noncardiovascular mortality in patients starting dialysis compared with the general population, was 1.09 ( 95% CI, 1.06-1.12). Relative excess in a sensitivity analysis in which unknown/missing causes of death were regarded either as noncardiovascular or cardiovascular varied between 0.90 ( 95% CI, 0.88-0.93) and 1.39 ( 95% CI, 1.35-1.43). Conclusion Patients starting dialysis have a generally increased risk of death that is not specifically caused by excess cardiovascular mortality. JAMA. 2009; 302(16):1782-1789 www.jama.com
引用
收藏
页码:1782 / 1789
页数:8
相关论文
共 40 条
[1]
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[2]
[Anonymous], 1992, INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS 1 INT STAT CLASS DIS
[3]
Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study [J].
Aucella, Filippo ;
Maas, Renke ;
Vigilante, Mimmo ;
Tripepi, Giovanni ;
Schwedhelm, Edzard ;
Margaglione, Maurizio ;
Gesualdo, Loreto ;
Boeger, Rainer ;
Zoccali, Carmine .
ATHEROSCLEROSIS, 2009, 207 (02) :541-545
[4]
BLOEMBERGEN WE, 1994, J AM SOC NEPHROL, V5, P1231
[5]
Cardiac diseases in maintenance hemodialysis patients: Results of the HEMO Study [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Berkoben, M ;
Heyka, R ;
Kaufman, A ;
Lewis, J ;
Rocco, M ;
Toto, R ;
Windus, D ;
Ornt, D ;
Levey, AS .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2380-2389
[6]
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[7]
The effect of single and repeatedly high concentrations of C-reactive protein on cardiovascular and non-cardiovascular mortality in patients starting with dialysis [J].
den Elzen, Wendy P. J. ;
van Manen, Jeannette G. ;
Boeschoten, Elisabeth W. ;
Krediet, Raymond T. ;
Dekker, Friedo W. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (06) :1588-1595
[8]
*ERA EDTA REG, 2007, ERA EDTA REG 2006 AN, P129
[9]
*EUR COMM, CAUS DEATH ABS NUMB
[10]
*EUR COMM, POP 1 JAN SEX AG 199